Addus HomeCare Corporation (ADUS)

NASDAQ: ADUS · USD

$122

+0.96 (+0.8%)· Recorded snapshot

Market cap	2.2B
Revenue (ttm)	1.5B
Net income (ttm)	105.3M
EPS (ttm)	$5.71
Shares out	18.3M
P/E (trailing)	21.4x
P/E (forward)	17.0x
Volume	242,163
Beta	0.83

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5B
Net income (ttm): 105.3M
EPS (ttm): $5.71
P/E (trailing): 21.4x
P/E (forward): 17.0x
Market cap: 2.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17

P25 n/aP50 n/aP75 n/a

Trailing P/E21.4

P25 n/aP50 n/aP75 n/a

ROE9.7

P25 n/aP50 n/aP75 n/a

ROIC9.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ADUS indicators

Market & fundamental data

Available fields

274

Groups with data

Currency

USD

Showing 274 of 274 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001468328
Company name	Addus HomeCare Corporation
Country	United States
Country code	US
CUSIP number	006739106
Earnings date	2026-11-03
Earnings time	amc
Employees	50,659
Employees change	956
Employees growth	1.92%
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1979
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2009-10-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US0067391062
Last 10-K release date	2026-02-24
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$122.20
Price currency	USD
Sector	Healthcare
SIC code	8082
Stock price date	2026-10-28
Symbol	ADUS
U.S. state	Texas
Website	https://www.addus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	18.29x
Average P/E ratio (10Y)	35.34x
Average P/E ratio (3Y)	24.44x
Average P/E ratio (5Y)	27.49x
Earnings yield	4.67%
EV/Earnings	21.45x
EV/EBIT	15.7x
EV/EBITDA	14.07x
EV/FCF	14.59x
EV/Sales	1.53x
FCF / EV yield	6.85%
FCF yield	6.88%
Forward EV/Sales	1.45x
Forward P/E	16.96x
Forward P/S	1.44x
Graham number	89.78718
Graham upside	-26.97%
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$128.87
Lynch upside	4.81%
P/(FCF - SBC) ratio	16.47x
P/(OCF - SBC) ratio	15.6x
P/B ratio	1.93x
P/E ratio	21.41x
P/FCF ratio	14.53x
P/OCF ratio	13.85x
P/S ratio	1.52x
PEG ratio	1.51x
Price / tangible book value	55.25x
Price/EBITDA ratio	14.01x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.74%
EBITDA margin	10.87%
Effective tax rate	25.16%
FCF margin	10.48%
Gross margin	31.98%
Operating margin	9.74%
Pretax margin	9.53%
Profit margin	7.13%
Profit per employee	$2,079
Profitable quarters	59
Profitable years	14
Revenue per employee	$29,144
ROA	6.27%
ROA (5Y)	5.54%
ROCE	11.16%
ROE	9.71%
ROE (5Y)	8.66%
ROIC	9.32%
ROIC (5Y)	8.66%
SBC / revenue	1.23%
Tax / revenue	2.4%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	26.17%
EPS growth (Q)	24.17%
EPS growth (QoQ)	9.56%
EPS growth 10Y	21.6%
EPS growth 3Y	19.94%
EPS growth 5Y	19.12%
EPS growth quarters	6
EPS growth years	8
FCF growth	65.26%
FCF growth (Q)	81.76%
FCF growth (QoQ)	-23.65%
FCF growth 3Y	17.88%
FCF growth 5Y	24.68%
Gross profit growth	13.71%
Gross profit growth (Q)	4.64%
Gross profit growth 3Y	14.25%
Gross profit growth 5Y	12.49%
Net income growth	26.92%
Net income growth (Q)	25.19%
Net income growth (QoQ)	10.12%
Net income growth 3Y	25.07%
Net income growth 5Y	22.57%
Net income growth quarters	6
Net income growth years	8
OCF growth	61.72%
OCF growth (Q)	77.6%
OCF growth (QoQ)	-23.59%
OCF growth 3Y	16.38%
OCF growth 5Y	24.09%
Operating income growth	8.11%
Operating income growth (Q)	11.11%
Operating income growth 3Y	18.53%
Operating income growth 5Y	13.93%
Revenue growth	15.88%
Revenue growth (Q)	8.01%
Revenue growth (QoQ)	3.8%
Revenue growth 10Y	15.17%
Revenue growth 3Y	13.9%
Revenue growth 5Y	12.67%
Revenue growth quarters	55
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-7.6M
Depreciation and amortization	$16.7M
EBIT	$143.8M
EBITDA	$160.5M
EPS	$5.71
FCF per share	$8.46
Financing cash flow	$-106M
Free cash flow	$154.8M
Free cash flow minus SBC	$136.5M
Gross profit	$472.2M
Income taxes	$35.4M
Investing cash flow	$-48M
Net borrowing	$-108.7M
Net cash flow	$8.4M
Net income	$105.3M
Operating cash flow minus SBC	$144.2M
Operating income	$143.8M
Revenue	$1.5B
Stock-based compensation	$18.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.73
Book value per share	$62.76
Debt / EBITDA	0.62
Debt / equity	0.09
Debt / FCF	0.7
Goodwill	$1B
Interest coverage	14.46
Long-term assets	$1.2B
Long-term liabilities	$140.2M
Net cash (debt)	$-9.3M
Net cash / market cap	-0.41%
Net debt / EBITDA	0.06
Net debt / equity	0.01
Net debt / FCF	0.06
Piotroski F-Score	6
Property, plant and equipment	$64.9M
Shareholders' equity	$1.1B
Tangible book value	$40.7M
Tangible book value per share	$2.23
Total assets	$1.5B
Total cash	$99.6M
Total debt	$108.8M
Total liabilities	$308.3M
WACC	8.73%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.03
Current assets	$284.2M
Current liabilities	$168.1M
Current ratio	1.69
Net working capital	$29.5M
Quick ratio	1.46
Working capital	$116M
Working capital turnover	12.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.79%
Dividend yield	0%
Shareholder yield	-0.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	382.75%
10Y return CAGR	17.05%
10Y total return	382.75%
150-day SMA	$106.20
15Y price change	3,061.66%
15Y return CAGR	25.89%
15Y total return	3,061.66%
1D price change	0.79%
1M price change	7.82%
1M total return	7.82%
1W price change	3.4%
1W total return	3.4%
1Y price change	0.48%
1Y return CAGR	0.48%
1Y total return	0.48%
20-day SMA	$116.51
200-day SMA	$106.20
3M price change	5.53%
3M total return	5.53%
3Y price change	48.96%
3Y return CAGR	14.2%
3Y total return	48.96%
50-day SMA	$116.82
50-day SMA vs 200-day SMA	50over200
52-week high	$124.44
52-week high date	2025-11-04
52-week low	$87.95
52-week low date	2026-06-03
5Y price change	46.05%
5Y return CAGR	7.87%
5Y total return	46.05%
6M price change	24.35%
6M total return	24.35%
All-time high	$136.72
All-time high date	2025-01-22
All-time low	$2.80
All-time low date	2010-11-01
Average true range (ATR)	$2.76
Average volume	181.3K
Beta (1Y)	0.34
Beta (2Y)	0.25
Beta (5Y)	0.83
Change from 52-week high	-1.8%
Change from 52-week low	38.94%
Change from all-time high	-10.74%
Change from all-time low	4,258.57%
Change from open	0.73%
Day's gap	0.06%
Dollar volume	$29.6M
High price	$122.50
Low price	$121.31
Monthly RSI	58.1
Open price	$121.31
Position in 52-week range	74.79%
Premarket change	-1.01%
Premarket close	$121.24
Premarket price	$120.01
Premarket volume	1K
Previous close	$121.24
Price vs 150-day SMA	14.91%
Price vs 20-day SMA	4.75%
Price vs 200-day SMA	14.91%
Price vs 50-day SMA	4.47%
Relative volume	1.34
RSI	66.4
Sharpe ratio	0.02
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	0.32
Sortino ratio	0.22
Sortino ratio (3Y)	0.91
Sortino ratio (5Y)	0.6
Volume	242.2K
Weekly RSI	62.56
YTD price change	13.64%
YTD total return	13.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17.8M
Float percentage	97.04%
Shares change (QoQ)	-0.08%
Shares change (YoY)	0.79%
Shares held by insiders	2.91%
Shares held by institutions	107.41%
Shares outstanding	18.3M
Short % of float	5.2%
Short % of shares	5.04%
Short ratio	4.2 days

Deeper analysis on ADUS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ADUS report

Is a complete ADUS research report available?

No complete published report is available for Addus HomeCare Corporation (ADUS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Addus HomeCare Corporation (ADUS)

Price

Financial snapshot

Fair-value bridge

Latest news · ADUS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADUS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ADUS

Frequently asked questions